Patent · US Active

Sulfur-containing bicyclic compound

US9051339B2 · kind B2 · utility

0Cited by

0References

14Claims

0Family size

Assignee

ASTELLAS PHARMA INC. · JP

Inventors

Nobuyuki Shiraishi · Tokyo, JP
Hiroaki Hoshii · Tokyo, JP
Wataru Hamaguchi · Tsukuba, JP
Eriko Honjo · Tokyo, JP
Tomofumi Takuwa · Tokyo, JP
Yuji Kondo · Tokyo, JP
Takayuki Goto · Tokyo, JP

Key dates

Filing date	Oct 17, 2014
Grant date	Jun 9, 2015
Priority date	—
Expiry date	Oct 17, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A sulfur-containing bicyclic compound having a PAM action of GABAB, and it use for preventing and/or treating schizophrenia, CIAS, cognitive impairment, fragile X syndrome, autism spectrum disorder, spasticity, anxiety disorder, substance addiction, pain, fibromyalgia, or Charcot-Marie-Tooth disease. A pharmaceutical composition for preventing and/or treating schizophrenia, cognitive impairment associated with schizophrenia (CIAS), cognitive impairment, fragile X syndrome, autism spectrum disorder, spasticity, anxiety disorder, substance addiction, pain, fibromyalgia, Charcot-Marie-Tooth disease, or the like, which has a positive allosteric modulator (PAM action) of GABAB.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.